Latest Asx News

Income Asset Management has resolved a protracted legal dispute with BGC involving former employees, agreeing to a $1.9 million settlement. A key shareholder has stepped in with a liquidity facility to support the company’s payment obligations.

Pinnacle Investment Management Group Limited has announced a fully franked ordinary dividend of AUD 0.29 per share for the half-year ending December 2025, with a dividend reinvestment plan available to shareholders.

Pinnacle Investment Management reported an 11% drop in net profit after tax for the first half of FY26, despite record net inflows and a strategic move to fully acquire Pacific Asset Management.

CVC Limited forecasts a substantial increase in its half-year net loss, prompting the board to suspend the interim dividend amid cashflow concerns.

The Federal Court of Australia has approved the acquisition schemes for Global Uranium and Enrichment Limited by Snow Lake Resources, setting the stage for a significant shift in shareholder structure and market listing.

Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition by Adamantem Capital-controlled entities, clearing a critical hurdle for the $500 million deal.

St George Mining has released a comprehensive investor presentation spotlighting its Araxá Project in Brazil, positioning itself as a major global player in niobium and rare earth elements with significant resource expansion and strategic partnerships underway.

The Federal Court of Australia has approved Caterpillar’s acquisition of mining software leader RPMGlobal, paving the way for a $5 per share payout to shareholders and a pending ASX trading halt.

OncoSil Medical Ltd has launched an $8 million equity raising to fund the commercial expansion and clinical development of its targeted radiotherapy device for pancreatic cancer, aiming to capitalise on growing European market adoption and upcoming trial catalysts.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Lode Resources is progressing its high-grade silver, antimony, gold, and tin projects in Tasmania and New South Wales, highlighted by robust drilling results and promising metallurgical tests. The company is advancing towards resource estimation and pilot production at Montezuma while expanding exploration across multiple targets.